OpenLB
Open Library of Bioscience
Advanced Search
Journal of cancer survivorship : research and practice
08, 2022;16 (4): 844-852.

Change in worry over time among Hispanic women with thyroid cancer.

Nina Jackson Levin, Anao Zhang, David Reyes-Gastelum, Debbie W Chen, Ann S Hamilton, Bradley Zebrack, Megan R Haymart
Author Information
  1. Nina Jackson Levin: School of Social Work and Department of Anthropology, University of Michigan, 1080 S. University Ave, Room B660, Ann Arbor, MI, 48109, USA. ORCID
  2. Anao Zhang: School of Social Work, University of Michigan, 1080 S. University, Room 3704, Ann Arbor, MI, 48109, USA. ORCID
  3. David Reyes-Gastelum: Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, North Campus Research Complex, 2800 Plymouth Rd. Bldg. 16, 400S-20, MI, 48109, Ann Arbor, USA. ORCID
  4. Debbie W Chen: Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Domino's Farms (Lobby C, Suite 1300), 24 Frank Lloyd Wright Drive, PO Box 451, Ann Arbor, MI, 48106, USA. ORCID
  5. Ann S Hamilton: Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 2001 N. Soto St., SSB318E, MC9239, Los Angeles, CA, 90089-9239, USA. ORCID
  6. Bradley Zebrack: School of Social Work, University of Michigan, 1080 S. University, Room 2778, Ann Arbor, MI, 48109, USA. ORCID
  7. Megan R Haymart: Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Bldg 16, Rm 408E, Ann Arbor, MI, 48109, USA. meganhay@med.umich.edu. ORCID
PMID: 34633638 DOI: 10.1007/s11764-021-01078-8

Abstract

PURPOSE: The purpose of this study is to assess change in worry over time in Hispanic women with thyroid cancer.
METHODS: Worry about recurrence, quality of life, family at risk, death, and harm from treatments was assessed in 273 Hispanic women with thyroid cancer diagnosed in 2014-2015. Subjects were recruited from Surveillance, Epidemiology, and End Results (SEER) Los Angeles. Participants were surveyed at two points in time (time 1: 2017-2018 and time 2: 2019). Multivariable logistic regression was used to determine correlates with high worry (somewhat, quite a bit, very much) versus low worry (not at all, a little) at time 2.
RESULTS: For the five worry items, 20.1-39.6% had high worry at both time 1 and time 2. An additional 7.6-13.4% had low worry at time 1 that became high worry at time 2. In multivariable logistic regression controlling for age, recurrence status, education level, and number of complications or side effects symptoms, younger age (20-39) as compared to older (40-79) was associated with high worry about thyroid cancer recurrence (OR 2.16, 95% CI 1.12-4.17). History of recurrent or persistent disease was associated with high worry about harms from treatment (OR 2.94, 95% CI 1.29-6.67). Greater number of complications or side effects of symptoms was associated with more worry across all five items.
CONCLUSIONS: Some Hispanic women with thyroid cancer have persistently high worry, with young adult Hispanic women vulnerable to worry about recurrence.
IMPLICATIONS FOR cancer SURVIVORS: Hispanic women with thyroid cancer may benefit from targeted psychosocial support during survivorship, with interventions informed by patient and cancer characteristics.

Keywords

AYA Psychosocial Survivorship Thyroid cancer Women Worry

References

  1. J Clin Oncol. 2019 Aug 20;37(24):2152-2161 [PMID: 31283406]
  2. Support Care Cancer. 2016 Nov;24(11):4727-37 [PMID: 27352837]
  3. J Cancer Surviv. 2021 Jun;15(3):418-426 [PMID: 32939685]
  4. CA Cancer J Clin. 2018 Nov;68(6):425-445 [PMID: 30285281]
  5. J Palliat Care. 2012 Summer;28(2):83-9 [PMID: 22860380]
  6. Thyroid. 2019 Aug;29(8):1080-1088 [PMID: 31232194]
  7. J Cancer Surviv. 2014 Mar;8(1):131-42 [PMID: 24222081]
  8. J Clin Oncol. 2018 Apr 10;36(11):1103-1111 [PMID: 29494259]
  9. J Clin Oncol. 2019 Nov 10;37(32):3042-3049 [PMID: 31573822]
  10. JAMA Otolaryngol Head Neck Surg. 2019 Sep 01;145(9):823-829 [PMID: 31318375]
  11. J Clin Oncol. 2013 Jun 10;31(17):2160-6 [PMID: 23650425]
  12. J Adolesc Young Adult Oncol. 2015 Dec;4(4):192-9 [PMID: 27077153]
  13. Cancer. 2017 Aug 15;123(16):3022-3030 [PMID: 28398629]
  14. Front Psychol. 2020 Nov 02;11:580979 [PMID: 33224072]
  15. J Cancer Surviv. 2019 Feb;13(1):34-42 [PMID: 30604138]
  16. Psychooncology. 2019 Apr;28(4):675-686 [PMID: 30703261]
  17. Support Care Cancer. 2016 Nov;24(11):4669-78 [PMID: 27378380]
  18. J Clin Endocrinol Metab. 2021 Jun 16;106(7):e2680-e2687 [PMID: 33660770]
  19. Cancer. 2020 Apr 1;126(7):1512-1521 [PMID: 31869452]
  20. Psychooncology. 2018 Jan;27(1):295-301 [PMID: 28727897]
  21. Psychooncology. 2017 Nov;26(11):1799-1809 [PMID: 27421919]
  22. Psychooncology. 2018 Sep;27(9):2155-2164 [PMID: 29843190]
  23. J Adolesc Young Adult Oncol. 2020 Aug;9(4):540-545 [PMID: 32255694]
  24. Thyroid. 2015 Jun;25(6):649-56 [PMID: 25809716]
  25. Oncol Nurs Forum. 2007 May;34(3):673-80 [PMID: 17573326]
  26. J Cancer Surviv. 2013 Sep;7(3):300-22 [PMID: 23475398]
  27. Neuropsychiatr Dis Treat. 2019 Apr 08;15:857-865 [PMID: 31118635]
  28. Psychooncology. 2014 Feb;23(2):237-40 [PMID: 24105759]
  29. Ann Surg Oncol. 2011 May;18(5):1312-8 [PMID: 21140230]
  30. Thyroid. 2018 Oct 26;: [PMID: 30244657]
  31. J Clin Oncol. 2010 Nov 10;28(32):4862-7 [PMID: 20855821]
  32. Psychooncology. 2008 Dec;17(12):1172-9 [PMID: 18457339]
  33. J Natl Cancer Inst Monogr. 2007;(37):16-21 [PMID: 17951226]
  34. Support Care Cancer. 2018 May;26(5):1479-1487 [PMID: 29168035]
  35. Surgery. 2020 Jan;167(1):102-109 [PMID: 31582311]
  36. Br J Oral Maxillofac Surg. 2017 Sep;55(7):666-673 [PMID: 28648407]
  37. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6060-6068 [PMID: 31415089]
  38. Thyroid. 2020 Sep;30(9):1297-1305 [PMID: 32183609]
  39. Pediatr Blood Cancer. 2019 Aug;66(8):e27789 [PMID: 31058418]
  40. J Clin Endocrinol Metab. 2015 Mar;100(3):977-85 [PMID: 25393643]
  41. Laryngoscope. 2015 Nov;125(11):2621-5 [PMID: 26153252]
  42. J Cancer Surviv. 2014 Sep;8(3):394-401 [PMID: 24570216]
  43. Thyroid. 2021 May;31(5):752-759 [PMID: 32838705]
  44. Am J Prev Med. 2014 Mar;46(3 Suppl 1):S87-97 [PMID: 24512936]
  45. Thyroid. 2017 Jun;27(6):762-772 [PMID: 28294040]
  46. J Cancer Surviv. 2016 Aug;10(4):663-73 [PMID: 26782171]
  47. Psychooncology. 2013 Apr;22(4):936-9 [PMID: 22419546]
  48. Cancer. 2011 May 1;117(9):1827-36 [PMID: 21445916]
  49. Qual Life Res. 2017 Jul;26(7):1659-1672 [PMID: 28251543]

Grants

  1. NU58DP006344/NCCDPHP CDC HHS
  2. U58 DP003875/NCCDPHP CDC HHS
  3. HHSN261201800015I/NCI NIH HHS
  4. T32 CA236621/NCI NIH HHS
  5. T32 DK007245/NIDDK NIH HHS
  6. HHSN261201800015C/NCI NIH HHS
  7. R01 CA201198/NCI NIH HHS
  8. HHSN261201800003C/NCI NIH HHS
  9. R01 HS024512/AHRQ HHS

MeSH Term

Anxiety
Female
Hispanic or Latino
Humans
Neoplasm Recurrence, Local
Quality of Life
Thyroid Neoplasms
Young Adult
Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.
Article has an altmetric score of 6

Word Cloud

Created with Highcharts 10.0.0worrytimecancerHispanicwomenthyroidhigh2recurrence1associatedWorrylogisticregressionlowfiveitemsagenumbercomplicationssideeffectssymptomsOR95%CIPURPOSE:purposestudyassesschangeMETHODS:qualitylifefamilyriskdeathharmtreatmentsassessed273diagnosed2014-2015SubjectsrecruitedSurveillanceEpidemiologyEndResultsSEERLosAngelesParticipantssurveyedtwopoints1:2017-20182:2019MultivariableuseddeterminecorrelatessomewhatquitebitmuchversuslittleRESULTS:201-396%additional76-134%becamemultivariablecontrollingstatuseducationlevelyounger20-39comparedolder40-791612-417Historyrecurrentpersistentdiseaseharmstreatment9429-667GreateracrossCONCLUSIONS:persistentlyyoungadultvulnerableIMPLICATIONSFORCANCERSURVIVORS:maybenefittargetedpsychosocialsupportsurvivorshipinterventionsinformedpatientcharacteristicsChangeamongAYAPsychosocialSurvivorshipThyroidWomen

Similar Articles

Cited By (5)